| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/10/2009 | US20090226552 Agents and methods for diagnosing osteoarthritis |
| 09/10/2009 | US20090226505 NELL Peptide Expression Systems and Bone Formation Activity of NELL Peptide |
| 09/10/2009 | US20090226488 Vaccine comprising an attenuated pestivirus |
| 09/10/2009 | US20090226486 N protein mutants of porcine reproductive and respiratory syndrome virus |
| 09/10/2009 | US20090226485 Vaccination of pigs against disease by administering a first recombinant porcine adenovirus vector stably expressing a heterologous nucleotide sequence encoding the antigenic determinant of the disease, preferably Hog Cholera Virus or Pseudorabies virus |
| 09/10/2009 | US20090226480 Streptococcus uberis adhesion molecule |
| 09/10/2009 | US20090226478 Early detection of flaviviruses using the NS1 glycoprotein |
| 09/10/2009 | US20090226473 Lymphocyte surface receptor that binds caml and methods of use thereof |
| 09/10/2009 | US20090226472 Interleukin-4 receptors |
| 09/10/2009 | US20090226470 Compositions and methods related to mRNA translational enhancer elements |
| 09/10/2009 | US20090226469 Shiga Toxoid Chimeric Proteins |
| 09/10/2009 | US20090226466 Therapeutic anti-her2 antibody fusion polypeptides |
| 09/10/2009 | US20090226462 use of polypeptide in a vaccine for protection of fish from Aeromomas |
| 09/10/2009 | US20090226460 Compositions and methods for the treatment of disease |
| 09/10/2009 | US20090226457 antibody that is immunoreactive with a polypeptide used in treating autoimmune and immunological diseases |
| 09/10/2009 | US20090226456 screening methods for identifying agonists and antagonists of TNFR-6 alpha & -6 beta activity; diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating immune system-related disorders; cancer |
| 09/10/2009 | US20090226451 Novel 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 molecules and uses therefor |
| 09/10/2009 | US20090226450 Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor |
| 09/10/2009 | US20090226449 Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921, and 33751 molecules and uses therefor |
| 09/10/2009 | US20090226448 Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses therefor |
| 09/10/2009 | US20090226447 Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof |
| 09/10/2009 | US20090226446 Method to Inhibit the Propagation of an Undesired Cell Population |
| 09/10/2009 | US20090226445 Plasmodium malariae and plasmodium ovale genes and uses thereof |
| 09/10/2009 | US20090226444 Pharmaceutical antibody compositions with resistance to soluble cea |
| 09/10/2009 | US20090226436 Novel receptors |
| 09/10/2009 | US20090226430 Recombinant anti-cd4 antibodies for human therapy |
| 09/10/2009 | US20090226428 Anti-inflammatory dab |
| 09/10/2009 | US20090226425 Diagnostics and Therapeutics For Glaucoma |
| 09/10/2009 | US20090226417 Human B7 polypeptides |
| 09/10/2009 | US20090226415 Modified tridegins, production and use thereof as transglutaminase inhibitors |
| 09/10/2009 | US20090226404 Methods for Generating Antigen-Specific Effector T Cells |
| 09/10/2009 | US20090226403 Olfactory and pheromones G-protein coupled receptors |
| 09/10/2009 | US20090226387 Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of cellular relaxation |
| 09/10/2009 | US20090226375 MICRO-RNAs THAT MODULATE SMOOTH MUSCLE PROLIFERATION AND DIFFERENTIATION AND USES THEREOF |
| 09/10/2009 | DE29925020U1 Zusammengesetzte Arrays mit Mikrokügelchen Composite arrays with microspheres |
| 09/10/2009 | DE102004064095B4 Promotoren und deren Verwendung Promoters and their use |
| 09/09/2009 | EP2098598A1 Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis c |
| 09/09/2009 | EP2098597A1 Method for manufacturing L-amino acids using improved strains of the enterobacteriaceae family |
| 09/09/2009 | EP2098595A1 Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 09/09/2009 | EP2098594A1 NUCLEIC ACID MOLECULE CAPABLE OF BINDING TO RABBIT-DERIVED IgG ANTIBODY |
| 09/09/2009 | EP2098593A1 hTERT expression regulatory gene |
| 09/09/2009 | EP2098591A1 Hybridoma capable of producing anti-dectin-1 monoclonal antibody |
| 09/09/2009 | EP2098538A1 Molecular module |
| 09/09/2009 | EP2098246A1 Method for promoting immune response comprising inhibiting cd22 function in b cells |
| 09/09/2009 | EP2097538A2 Transcriptional regulatory elements of biological pathways, tools, and methods |
| 09/09/2009 | EP2097533A2 Viral vector and uses thereof |
| 09/09/2009 | EP2097532A1 Nucleic acid molecules encoding plant proteins in the c3hc4 family and methods for the alteration of plant cellulose and lignin content |
| 09/09/2009 | EP2097531A2 Methods of obtaining genetic competence in bacillus cells |
| 09/09/2009 | EP2097530A1 Compositions and methods for the expression of nucleic acids |
| 09/09/2009 | EP2097529A1 Methods of selecting and producing modified toxins, conjugates containing modified toxins and uses thereof |
| 09/09/2009 | EP2097528A2 Butanol production in a eukaryotic cell |
| 09/09/2009 | EP2097527A2 Oligonucleotides for modulating target rna activity |
| 09/09/2009 | EP2097526A2 Expression system of nell peptide |
| 09/09/2009 | EP2097525A1 Methods of reducing or eliminating expression of genes in filamentous fungal strains by transitive rna interference |
| 09/09/2009 | EP2097524A2 Method for the random diversification of a genetic sequence while preserving the identity of some inner segments of said genetic sequence |
| 09/09/2009 | EP2097522A2 Method, kit and initiators for genetic identification of mycobacterium bovis bcg variety moreau-rj, method for monitoring feasibility of bcg moreau-rj and expression of genes, and products with immunological activity |
| 09/09/2009 | EP2097520A1 A method for producing n-terminal methioine free polypeptides in microbial host cells |
| 09/09/2009 | EP2097517A2 Modified vaccinia virus strains for use in diagnostic and therapeutic methods |
| 09/09/2009 | EP2097456A1 Fusion protein of immunoglobulin fc and human apolipoprotein(a) kringle fragment |
| 09/09/2009 | EP2097454A2 4-1 bb ligand in inflammatory diseases |
| 09/09/2009 | EP2097453A2 Monoclonal antibodies against the human anti-müllerian hormone type ii receptor (amhr-ii) |
| 09/09/2009 | EP2097452A1 Delivery of binding molecules to induce immunomodulation |
| 09/09/2009 | EP2097444A2 Transgenic animal with enhanced immune response and method for the preparation thereof |
| 09/09/2009 | EP2097104A2 New a-beta conformer selective anti-a-beta globulomer monoclonal antibodies |
| 09/09/2009 | EP2097096A1 Modified coagulation factors with prolonged in vivo half-life |
| 09/09/2009 | EP2097095A2 Myostatin inhibition for enhancing muscle and/or improving muscle function |
| 09/09/2009 | EP2096910A2 Transgenic mammals modified bri protein expression |
| 09/09/2009 | EP2096909A2 Polynucleotides and polypeptides involved in plant fiber development and methods of using same |
| 09/09/2009 | EP1968372A4 Promoter sequence obtained from rice and methods of use |
| 09/09/2009 | EP1959725A4 Increased seed size and seed number through transgenic over expression of a growth and/or development related gene during early embryo development |
| 09/09/2009 | EP1943338A4 Cell-free synthesis of membrane bound polypeptides |
| 09/09/2009 | EP1910536B1 Methods for identifying genes that increase yeast stress tolerance, and use of these genes for yeast strain improvement |
| 09/09/2009 | EP1885848A4 Microbial conversion of sugar acids and means useful therein |
| 09/09/2009 | EP1851321B1 Hiv epitopes and pharmaceutical composition containing same |
| 09/09/2009 | EP1802653B1 Mam domain containing protein |
| 09/09/2009 | EP1781083A4 Brassica indehiscent1 sequences |
| 09/09/2009 | EP1751283B1 Fed-batch fermentation process and culture medium for the production of plasmid dna in e.coli on a manufacturing scale |
| 09/09/2009 | EP1723246B1 New expression tools for multiprotein applications |
| 09/09/2009 | EP1709179B1 Transgenic plants with reduced level of saturated fatty acid and methods for making them |
| 09/09/2009 | EP1644506B1 A method for obtaining improved fertility restorer lines for transgenic male sterile crop plants and a dna construct for use in said method |
| 09/09/2009 | EP1575977B1 Immunostimulatory sequence oligonucleotides and methods of using the same |
| 09/09/2009 | EP1548028B1 Substituted type peptides of wt1 |
| 09/09/2009 | EP1517918B9 Peptides having affinity for a phospholipid and uses |
| 09/09/2009 | EP1509621B1 Diagnostic of alzheimer's disease by analysis of il-10 gene polymorphisms |
| 09/09/2009 | EP1446733B1 Glycosylphosphatidylinositol containing polypeptides |
| 09/09/2009 | EP1409647A4 Composite scaffolds and methods using same for generating complex tissue grafts |
| 09/09/2009 | EP1290027B1 Immunoadhesin for the prevention of rhinovirus infection |
| 09/09/2009 | EP1279735B1 Malaria plasmodium antigen polypeptide se36, method of purifying the same and vaccine and diagnostic with the use of the thus obtained antigen |
| 09/09/2009 | EP1181372B1 Viral expression vectors for plants |
| 09/09/2009 | EP1102857B1 Controlling starch synthesis |
| 09/09/2009 | EP1100935B1 Mutant e.coli strains, and their use for producing recombinant polypeptides |
| 09/09/2009 | EP1098992B1 Nucleic acid detection method by triple helix formation |
| 09/09/2009 | EP1098962B1 Diacylglycerol acyl transferase proteins |
| 09/09/2009 | EP1029063B1 Non rcr leuconostoc plasmid capable of being transferred into lactic acid bacteria; use as cloning and expressing tool |
| 09/09/2009 | EP1015488B1 Interleukin-17 receptor-like protein |
| 09/09/2009 | EP1002068B1 Mutations in the myostatin gene cause double-muscling in mammals |
| 09/09/2009 | EP0996857B1 Cancer associated nucleic acids and polypeptides |
| 09/09/2009 | EP0861261B1 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 09/09/2009 | EP0817847B2 Il-17 receptor |
| 09/09/2009 | EP0813545B1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon |